Fed-fasted BE studies using different polymorphs [Regulatives / Guidelines]

posted by Ohlbe – France, 2009-08-31 03:34 (5644 d 23:16 ago) – Posting: # 4137
Views: 4,522

Dear London and Helmut,

❝ ❝ [...] the fasted study will be repeated.


❝ Danger! I would say that the part about mandatory submission of all studies from the 2008 BE drafted guideline will survive and make it to the final version.


Independently of the guideline, for EU submissions Annex I to Directive 2001/83/EC, as amended by Directive 2003/63/EC, requires that all clinical trials conducted on the product be submitted, whether positive or negative.

A lot of fuss has been made about this paragraph in the draft EU guideline. There was nothing new in it: this requirement is in place since at least 1975 (Annex to Directive 75/318/EC).

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
44 visitors (0 registered, 44 guests [including 5 identified bots]).
Forum time: 01:51 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5